CALMOMUSC LIQ 6.3 %
MENTHYL SALICYLATE : 6.3 % MENTHOL : 3.17 % EUCALYPTOL : 2.1 % · DIN 00777749 · CARDINAUX ENRG LES PRODUITS NATURELS
Health Canada status: CANCELLED POST MARKET
What is CALMOMUSC LIQ?
CALMOMUSC LIQ 6.3 % contains MENTHYL SALICYLATE : 6.3 % MENTHOL : 3.17 % EUCALYPTOL : 2.1 %. It is listed in the Health Canada Drug Product Database under DIN 00777749, held by CARDINAUX ENRG LES PRODUITS NATURELS, supplied as LIQUID for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 07-Jul-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00777749 |
|---|---|
| Brand name | CALMOMUSC LIQ |
| Generic / active ingredient | MENTHYL SALICYLATE : 6.3 % MENTHOL : 3.17 % EUCALYPTOL : 2.1 % |
| Manufacturer | CARDINAUX ENRG LES PRODUITS NATURELS |
| Strength | 6.3 % |
| Dosage form | LIQUID |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES |
| AHFS class | 28:08.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 07-Jul-2000 |
| Original market date | 1989-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES. 11 of 120 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ARTHRITIS PAIN RELIEF | 10 % | LOTION | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02486725 |
| EXTRA STRENGTH ASPERCREME CREME RUB 15% | 15 % | CREAM | SANOFI CONSUMER HEALTH INC | MARKETED | DIN 02074702 |
| FLEXACRÈME PAIN RELIEF RUB | 15 % | CREAM | CRLS | MARKETED | DIN 02516713 |
| MUSCLE & JOINT NO ODOUR EXTRA STRENGTH | 20 % | CREAM | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02473135 |
| MUSCLE & JOINT NO ODOUR REGULAR STRENGTH | 13.3 % | CREAM | CHURCH & DWIGHT CANADA CORP | MARKETED | DIN 02473143 |
| MYOFLEX EXTRA STRENGTH | 15 % | CREAM | EXZELL PHARMA INC | MARKETED | DIN 02226022 |
| MYOFLEX MAXIMUM STRENGTH | 20 % | CREAM | EXZELL PHARMA INC | MARKETED | DIN 02244573 |
| MYOFLEX REGULAR STRENGTH | 10 % | CREAM | EXZELL PHARMA INC | MARKETED | DIN 02152827 |
| PAIN RELIEF CREAM EXTRA STRENGTH | 20 % | CREAM | CRLS | MARKETED | DIN 02413442 |
| PAIN RELIEF CREAM REGULAR STRENGTH | 13.3 % | CREAM | CRLS | MARKETED | DIN 02358131 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.